Harrow, Inc., an eyecare pharmaceutical company, engages in the discovery, development, and commercialization of ophthalmic pharmaceutical products in the United States. It operates through Branded and ImprimisRx segments. The company offers ImprimisRx, an ophthalmology-focused compounded...
71 insider purchases on record · latest filing 2026-05-19.
Insiders have also filed 31 sale transactions at HROW.